MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on May 5, 2008; DOI: 10.1124/mol.107.044388


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.044388v1
74/2/466    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, T.-Y.
Right arrow Articles by Levandoski, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, T.-Y.
Right arrow Articles by Levandoski, M. M.


Received for publication December 21, 2007.
Revised April 5, 2008.
Accepted for publication April 29, 2008.

Morantel Allosterically Enhances Channel Gating of Neuronal Nicotinic Acetylcholine {alpha}3{beta}2 Receptors

Tse-Yu Wu 1, Caleb M. Smith 1, Steven M. Sine 2, Mark M. Levandoski 1*

1 Grinnell College 2 Mayo Clinic and Foundation

* Address correspondence to: E-mail: levandos{at}grinnell.edu

Abstract

We studied allosteric potentiation of rat {alpha}3{beta}2 neuronal nicotinic acetylcholine receptors (nAChRs) by the anthelmintic compound morantel. Macroscopic currents evoked by ACh from nAChRs expressed in Xenopus oocytes increase up to eight-fold in the presence of low concentrations of morantel (≤ 10 µM); the magnitude of the potentiation depends on both agonist and modulator concentrations. Importantly, the potentiated currents exceed the maximum currents achieved by saturating (mM) concentrations of agonist. Studies of macroscopic currents elicited by prolonged drug applications (100 - 300 s) indicate that morantel does not increase {alpha}3{beta}2 receptor activity by reducing slow (≥ 1 s) desensitization. Instead, using outside-out patch-clamp recordings, we demonstrate that morantel increases the frequency of single-channel openings and alters the bursting characteristics of the openings in a manner consistent with enhanced channel gating; these results quantitatively explain the macroscopic current potentiation. Morantel is a very weak agonist alone, but we show that the classical competitive antagonist dihydro-{beta}-erythroidine inhibits morantel-evoked currents noncompetitively, indicating that morantel does not bind to the canonical ACh binding sites.


Key words: Nicotinic cholinergic, Ion channel regulation, Single channel kinetics





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics